{"id":3912,"date":"2020-03-04T14:52:04","date_gmt":"2020-03-04T13:52:04","guid":{"rendered":"https:\/\/www.m-q.ch\/?p=3912"},"modified":"2020-03-04T14:52:04","modified_gmt":"2020-03-04T13:52:04","slug":"i-biosimilari-potrebbero-ridurre-drasticamente-i-costi-della-sanita","status":"publish","type":"post","link":"https:\/\/www.m-q.ch\/it\/i-biosimilari-potrebbero-ridurre-drasticamente-i-costi-della-sanita\/","title":{"rendered":"I biosimilari potrebbero ridurre drasticamente i costi sanitari"},"content":{"rendered":"<figure id=\"attachment_3913\" aria-describedby=\"caption-attachment-3913\" style=\"width: 680px\" class=\"wp-caption alignnone\"><img loading=\"lazy\" decoding=\"async\" class=\"size-medium wp-image-3913\" src=\"https:\/\/www.m-q.ch\/wp-content\/uploads\/2020\/03\/biosimiliars-Schweiz-_mq-management-u-qualitaet-680x510.jpg\" alt=\"\" width=\"680\" height=\"510\" srcset=\"https:\/\/www.m-q.ch\/wp-content\/uploads\/2020\/03\/biosimiliars-Schweiz-_mq-management-u-qualitaet-680x510.jpg 680w, https:\/\/www.m-q.ch\/wp-content\/uploads\/2020\/03\/biosimiliars-Schweiz-_mq-management-u-qualitaet-768x576.jpg 768w, https:\/\/www.m-q.ch\/wp-content\/uploads\/2020\/03\/biosimiliars-Schweiz-_mq-management-u-qualitaet-1536x1152.jpg 1536w, https:\/\/www.m-q.ch\/wp-content\/uploads\/2020\/03\/biosimiliars-Schweiz-_mq-management-u-qualitaet-2048x1536.jpg 2048w, https:\/\/www.m-q.ch\/wp-content\/uploads\/2020\/03\/biosimiliars-Schweiz-_mq-management-u-qualitaet-16x12.jpg 16w, https:\/\/www.m-q.ch\/wp-content\/uploads\/2020\/03\/biosimiliars-Schweiz-_mq-management-u-qualitaet-233x175.jpg 233w, https:\/\/www.m-q.ch\/wp-content\/uploads\/2020\/03\/biosimiliars-Schweiz-_mq-management-u-qualitaet-467x350.jpg 467w, https:\/\/www.m-q.ch\/wp-content\/uploads\/2020\/03\/biosimiliars-Schweiz-_mq-management-u-qualitaet-1067x800.jpg 1067w, https:\/\/www.m-q.ch\/wp-content\/uploads\/2020\/03\/biosimiliars-Schweiz-_mq-management-u-qualitaet-920x690.jpg 920w, https:\/\/www.m-q.ch\/wp-content\/uploads\/2020\/03\/biosimiliars-Schweiz-_mq-management-u-qualitaet-1400x1050.jpg 1400w, https:\/\/www.m-q.ch\/wp-content\/uploads\/2020\/03\/biosimiliars-Schweiz-_mq-management-u-qualitaet-1867x1400.jpg 1867w, https:\/\/www.m-q.ch\/wp-content\/uploads\/2020\/03\/biosimiliars-Schweiz-_mq-management-u-qualitaet-300x225.jpg 300w, https:\/\/www.m-q.ch\/wp-content\/uploads\/2020\/03\/biosimiliars-Schweiz-_mq-management-u-qualitaet-1024x768.jpg 1024w, https:\/\/www.m-q.ch\/wp-content\/uploads\/2020\/03\/biosimiliars-Schweiz-_mq-management-u-qualitaet-624x468.jpg 624w\" sizes=\"auto, (max-width: 680px) 100vw, 680px\" \/><figcaption id=\"caption-attachment-3913\" class=\"wp-caption-text\">Uno studio della ZHAW calcola le potenziali riduzioni dei costi sanitari solo per i sei principi attivi pi\u00f9 importanti. (Immagine: Unsplash)<\/figcaption><\/figure>\n<p class=\"bodytext\">La Svizzera potrebbe ridurre drasticamente i costi farmaceutici aumentando la prescrizione di biosimilari. Questa \u00e8 la conclusione di uno studio del Winterthur Institute for Health Economics (<a href=\"https:\/\/www.zhaw.ch\/de\/sml\/institute-zentren\/wig\/\" target=\"_blank\" rel=\"noopener\">TIG<\/a>) della ZHAW School of Management and Law (<a href=\"https:\/\/www.zhaw.ch\/de\/sml\/?pi=1825&amp;cHash=455ffccb9ab0ab263837ca9820641c01\" target=\"_blank\" rel=\"noopener\">SML<\/a>). \u00c8 affiliato all'Universit\u00e0 di Scienze Applicate di Zurigo (<a href=\"https:\/\/www.zhaw.ch\/de\/hochschule\/\" target=\"_blank\" rel=\"noopener\">ZHAW<\/a>) affiliato.<\/p>\n<p class=\"bodytext\">A differenza di altri paesi europei, i biosimilari sono usati solo con moderazione in Svizzera. Queste imitazioni di preparati originali che non sono pi\u00f9 protetti da brevetto non sono affatto inferiori agli originali in termini di efficacia e sicurezza. Allo stesso tempo, sono fino al 25% pi\u00f9 economici. Tuttavia, in Svizzera sono stati approvati meno biosimilari che nell'Unione europea. Inoltre, i medici hanno meno esperienza con i biosimilari che con i prodotti originali.<\/p>\n<p class=\"bodytext\">\"Siamo stati in grado di dimostrare nella nostra analisi che l'aumento dell'uso dei biosimilari in Svizzera potrebbe ridurre significativamente i costi dei farmaci dell'assicurazione sanitaria obbligatoria\", ha detto il capo dell'istituto di Winterthur, Simon Wieser, in un\u00a0<a href=\"https:\/\/www.zhaw.ch\/de\/ueber-uns\/aktuell\/news\/detailansicht-news\/event-news\/biosimilars-koennten-schweizer-gesundheitskosten-um-millionen-senken\/\" target=\"_blank\" rel=\"noopener\">Comunicato stampa<\/a>\u00a0citato. Gli autori stimano il risparmio potenziale per sei dei pi\u00f9 importanti principi attivi fino a 100 milioni di franchi svizzeri in tre anni. Per raggiungere questo obiettivo, ai nuovi pazienti dovrebbero essere prescritti pi\u00f9 biosimilari. Se anche le persone che avevano precedentemente assunto preparati originali fossero passate ai biosimilari, il risparmio sarebbe ancora maggiore.<\/p>\n<p class=\"bodytext\"><em>Il rapporto di esperti \"Biosimilari in Svizzera - Medicina per contrastare l'aumento dei costi sanitari?\" \u00e8 stato preparato dall'Istituto di economia sanitaria Winterthur su incarico di\u00a0<a href=\"https:\/\/www.pfizer.ch\/\" target=\"_blank\" rel=\"noopener\">Pfizer<\/a>\u00a0compilato<\/em><\/p>","protected":false},"excerpt":{"rendered":"<p>La Svizzera potrebbe ridurre drasticamente i costi dei farmaci aumentando la prescrizione di biosimilari. \u00c8 questa la conclusione di uno studio del Winterthur Institute of Health Economics (WIG) della ZHAW School of Management and Law (SML). L'istituto \u00e8 affiliato all'Universit\u00e0 di Scienze Applicate di Zurigo (ZHAW). A differenza di altri Paesi europei, in Svizzera i biosimilari vengono utilizzati solo con moderazione [...]<\/p>","protected":false},"author":35,"featured_media":3913,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"footnotes":""},"categories":[3303],"tags":[4247,4248,3490,4223],"class_list":["post-3912","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-qualitaetsmanagement","tag-arzneimittel","tag-kosten","tag-schweiz","tag-studien"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v26.2 - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\n<title>Biosimilars k\u00f6nnten Gesundheitskosten drastisch senken - MQ Management und Qualit\u00e4t<\/title>\n<meta name=\"description\" content=\"Die Schweiz sch\u00f6pft das Sparpotenzial bei bestimmten nachgeahmten Medikamenten, sogenannten Biosimilars, bei weitem nicht aus, belegt eine ZHAW Studie.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.m-q.ch\/it\/i-biosimilari-potrebbero-ridurre-drasticamente-i-costi-della-sanita\/\" \/>\n<meta property=\"og:locale\" content=\"it_IT\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Biosimilars k\u00f6nnten Gesundheitskosten drastisch senken - MQ Management und Qualit\u00e4t\" \/>\n<meta property=\"og:description\" content=\"Die Schweiz sch\u00f6pft das Sparpotenzial bei bestimmten nachgeahmten Medikamenten, sogenannten Biosimilars, bei weitem nicht aus, belegt eine ZHAW Studie.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.m-q.ch\/it\/i-biosimilari-potrebbero-ridurre-drasticamente-i-costi-della-sanita\/\" \/>\n<meta property=\"og:site_name\" content=\"MQ Management und Qualit\u00e4t\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/ManagementUndQualitaet\" \/>\n<meta property=\"article:published_time\" content=\"2020-03-04T13:52:04+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.m-q.ch\/wp-content\/uploads\/2020\/03\/biosimiliars-Schweiz-_mq-management-u-qualitaet-scaled.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"2560\" \/>\n\t<meta property=\"og:image:height\" content=\"1920\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"Roger Str\u00e4ssle\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Scritto da\" \/>\n\t<meta name=\"twitter:data1\" content=\"Roger Str\u00e4ssle\" \/>\n\t<meta name=\"twitter:label2\" content=\"Tempo di lettura stimato\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minuto\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/www.m-q.ch\/biosimilars-koennten-gesundheitskosten-drastisch-senken\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/www.m-q.ch\/biosimilars-koennten-gesundheitskosten-drastisch-senken\/\"},\"author\":{\"name\":\"Roger Str\u00e4ssle\",\"@id\":\"https:\/\/www.m-q.ch\/fr\/#\/schema\/person\/47d540e081acd98ccbeb69b55df653d7\"},\"headline\":\"Biosimilars k\u00f6nnten Gesundheitskosten drastisch senken\",\"datePublished\":\"2020-03-04T13:52:04+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/www.m-q.ch\/biosimilars-koennten-gesundheitskosten-drastisch-senken\/\"},\"wordCount\":268,\"publisher\":{\"@id\":\"https:\/\/www.m-q.ch\/fr\/#organization\"},\"image\":{\"@id\":\"https:\/\/www.m-q.ch\/biosimilars-koennten-gesundheitskosten-drastisch-senken\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/www.m-q.ch\/wp-content\/uploads\/2020\/03\/biosimiliars-Schweiz-_mq-management-u-qualitaet-scaled.jpg\",\"keywords\":[\"Arzneimittel\",\"Kosten\",\"Schweiz\",\"Studien\"],\"articleSection\":[\"Qualit\u00e4tsmanagement\"],\"inLanguage\":\"it-IT\"},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/www.m-q.ch\/biosimilars-koennten-gesundheitskosten-drastisch-senken\/\",\"url\":\"https:\/\/www.m-q.ch\/biosimilars-koennten-gesundheitskosten-drastisch-senken\/\",\"name\":\"Biosimilars k\u00f6nnten Gesundheitskosten drastisch senken - MQ Management und Qualit\u00e4t\",\"isPartOf\":{\"@id\":\"https:\/\/www.m-q.ch\/fr\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/www.m-q.ch\/biosimilars-koennten-gesundheitskosten-drastisch-senken\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/www.m-q.ch\/biosimilars-koennten-gesundheitskosten-drastisch-senken\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/www.m-q.ch\/wp-content\/uploads\/2020\/03\/biosimiliars-Schweiz-_mq-management-u-qualitaet-scaled.jpg\",\"datePublished\":\"2020-03-04T13:52:04+00:00\",\"description\":\"Die Schweiz sch\u00f6pft das Sparpotenzial bei bestimmten nachgeahmten Medikamenten, sogenannten Biosimilars, bei weitem nicht aus, belegt eine ZHAW Studie.\",\"breadcrumb\":{\"@id\":\"https:\/\/www.m-q.ch\/biosimilars-koennten-gesundheitskosten-drastisch-senken\/#breadcrumb\"},\"inLanguage\":\"it-IT\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/www.m-q.ch\/biosimilars-koennten-gesundheitskosten-drastisch-senken\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"it-IT\",\"@id\":\"https:\/\/www.m-q.ch\/biosimilars-koennten-gesundheitskosten-drastisch-senken\/#primaryimage\",\"url\":\"https:\/\/www.m-q.ch\/wp-content\/uploads\/2020\/03\/biosimiliars-Schweiz-_mq-management-u-qualitaet-scaled.jpg\",\"contentUrl\":\"https:\/\/www.m-q.ch\/wp-content\/uploads\/2020\/03\/biosimiliars-Schweiz-_mq-management-u-qualitaet-scaled.jpg\",\"width\":2560,\"height\":1920,\"caption\":\"Eine Studie der ZHAW errechnet allein bei den sechs wichtigsten Wirkstoffen m\u00f6gliche Kostensenkungen im Gesundheitswesen. (Bild: Unsplash)\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/www.m-q.ch\/biosimilars-koennten-gesundheitskosten-drastisch-senken\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Qualit\u00e4tsmanagement\",\"item\":\"https:\/\/www.m-q.ch\/kategorie\/qualitaetsmanagement\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Biosimilars k\u00f6nnten Gesundheitskosten drastisch senken\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/www.m-q.ch\/fr\/#website\",\"url\":\"https:\/\/www.m-q.ch\/fr\/\",\"name\":\"MQ Management und Qualit\u00e4t\",\"description\":\"Plattform f\u00fcr integrierte Managementsysteme.\",\"publisher\":{\"@id\":\"https:\/\/www.m-q.ch\/fr\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/www.m-q.ch\/fr\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"it-IT\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/www.m-q.ch\/fr\/#organization\",\"name\":\"Galledia Fachmedien AG\",\"url\":\"https:\/\/www.m-q.ch\/fr\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"it-IT\",\"@id\":\"https:\/\/www.m-q.ch\/fr\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/www.m-q.ch\/wp-content\/uploads\/2020\/12\/cropped-logo_small.png\",\"contentUrl\":\"https:\/\/www.m-q.ch\/wp-content\/uploads\/2020\/12\/cropped-logo_small.png\",\"width\":512,\"height\":512,\"caption\":\"Galledia Fachmedien AG\"},\"image\":{\"@id\":\"https:\/\/www.m-q.ch\/fr\/#\/schema\/logo\/image\/\"},\"sameAs\":[\"https:\/\/www.facebook.com\/ManagementUndQualitaet\",\"https:\/\/www.linkedin.com\/showcase\/17982321\/admin\/\"]},{\"@type\":\"Person\",\"@id\":\"https:\/\/www.m-q.ch\/fr\/#\/schema\/person\/47d540e081acd98ccbeb69b55df653d7\",\"name\":\"Roger Str\u00e4ssle\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"it-IT\",\"@id\":\"https:\/\/www.m-q.ch\/fr\/#\/schema\/person\/image\/\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/e4dde3046d8a184d2e2d27651a418883?s=96&d=mm&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/e4dde3046d8a184d2e2d27651a418883?s=96&d=mm&r=g\",\"caption\":\"Roger Str\u00e4ssle\"},\"url\":\"https:\/\/www.m-q.ch\/it\/author\/roger-straessle\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"I biosimilari potrebbero ridurre drasticamente i costi sanitari - MQ Management und Qualit\u00e4t","description":"La Svizzera \u00e8 lontana dallo sfruttare il potenziale di risparmio di alcuni farmaci di imitazione, i cosiddetti biosimilari, secondo uno studio della ZHAW.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.m-q.ch\/it\/i-biosimilari-potrebbero-ridurre-drasticamente-i-costi-della-sanita\/","og_locale":"it_IT","og_type":"article","og_title":"Biosimilars k\u00f6nnten Gesundheitskosten drastisch senken - MQ Management und Qualit\u00e4t","og_description":"Die Schweiz sch\u00f6pft das Sparpotenzial bei bestimmten nachgeahmten Medikamenten, sogenannten Biosimilars, bei weitem nicht aus, belegt eine ZHAW Studie.","og_url":"https:\/\/www.m-q.ch\/it\/i-biosimilari-potrebbero-ridurre-drasticamente-i-costi-della-sanita\/","og_site_name":"MQ Management und Qualit\u00e4t","article_publisher":"https:\/\/www.facebook.com\/ManagementUndQualitaet","article_published_time":"2020-03-04T13:52:04+00:00","og_image":[{"width":2560,"height":1920,"url":"https:\/\/www.m-q.ch\/wp-content\/uploads\/2020\/03\/biosimiliars-Schweiz-_mq-management-u-qualitaet-scaled.jpg","type":"image\/jpeg"}],"author":"Roger Str\u00e4ssle","twitter_card":"summary_large_image","twitter_misc":{"Scritto da":"Roger Str\u00e4ssle","Tempo di lettura stimato":"1 minuto"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.m-q.ch\/biosimilars-koennten-gesundheitskosten-drastisch-senken\/#article","isPartOf":{"@id":"https:\/\/www.m-q.ch\/biosimilars-koennten-gesundheitskosten-drastisch-senken\/"},"author":{"name":"Roger Str\u00e4ssle","@id":"https:\/\/www.m-q.ch\/fr\/#\/schema\/person\/47d540e081acd98ccbeb69b55df653d7"},"headline":"Biosimilars k\u00f6nnten Gesundheitskosten drastisch senken","datePublished":"2020-03-04T13:52:04+00:00","mainEntityOfPage":{"@id":"https:\/\/www.m-q.ch\/biosimilars-koennten-gesundheitskosten-drastisch-senken\/"},"wordCount":268,"publisher":{"@id":"https:\/\/www.m-q.ch\/fr\/#organization"},"image":{"@id":"https:\/\/www.m-q.ch\/biosimilars-koennten-gesundheitskosten-drastisch-senken\/#primaryimage"},"thumbnailUrl":"https:\/\/www.m-q.ch\/wp-content\/uploads\/2020\/03\/biosimiliars-Schweiz-_mq-management-u-qualitaet-scaled.jpg","keywords":["Arzneimittel","Kosten","Schweiz","Studien"],"articleSection":["Qualit\u00e4tsmanagement"],"inLanguage":"it-IT"},{"@type":"WebPage","@id":"https:\/\/www.m-q.ch\/biosimilars-koennten-gesundheitskosten-drastisch-senken\/","url":"https:\/\/www.m-q.ch\/biosimilars-koennten-gesundheitskosten-drastisch-senken\/","name":"I biosimilari potrebbero ridurre drasticamente i costi sanitari - MQ Management und Qualit\u00e4t","isPartOf":{"@id":"https:\/\/www.m-q.ch\/fr\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.m-q.ch\/biosimilars-koennten-gesundheitskosten-drastisch-senken\/#primaryimage"},"image":{"@id":"https:\/\/www.m-q.ch\/biosimilars-koennten-gesundheitskosten-drastisch-senken\/#primaryimage"},"thumbnailUrl":"https:\/\/www.m-q.ch\/wp-content\/uploads\/2020\/03\/biosimiliars-Schweiz-_mq-management-u-qualitaet-scaled.jpg","datePublished":"2020-03-04T13:52:04+00:00","description":"La Svizzera \u00e8 lontana dallo sfruttare il potenziale di risparmio di alcuni farmaci di imitazione, i cosiddetti biosimilari, secondo uno studio della ZHAW.","breadcrumb":{"@id":"https:\/\/www.m-q.ch\/biosimilars-koennten-gesundheitskosten-drastisch-senken\/#breadcrumb"},"inLanguage":"it-IT","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.m-q.ch\/biosimilars-koennten-gesundheitskosten-drastisch-senken\/"]}]},{"@type":"ImageObject","inLanguage":"it-IT","@id":"https:\/\/www.m-q.ch\/biosimilars-koennten-gesundheitskosten-drastisch-senken\/#primaryimage","url":"https:\/\/www.m-q.ch\/wp-content\/uploads\/2020\/03\/biosimiliars-Schweiz-_mq-management-u-qualitaet-scaled.jpg","contentUrl":"https:\/\/www.m-q.ch\/wp-content\/uploads\/2020\/03\/biosimiliars-Schweiz-_mq-management-u-qualitaet-scaled.jpg","width":2560,"height":1920,"caption":"Eine Studie der ZHAW errechnet allein bei den sechs wichtigsten Wirkstoffen m\u00f6gliche Kostensenkungen im Gesundheitswesen. (Bild: Unsplash)"},{"@type":"BreadcrumbList","@id":"https:\/\/www.m-q.ch\/biosimilars-koennten-gesundheitskosten-drastisch-senken\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Qualit\u00e4tsmanagement","item":"https:\/\/www.m-q.ch\/kategorie\/qualitaetsmanagement\/"},{"@type":"ListItem","position":2,"name":"Biosimilars k\u00f6nnten Gesundheitskosten drastisch senken"}]},{"@type":"WebSite","@id":"https:\/\/www.m-q.ch\/fr\/#website","url":"https:\/\/www.m-q.ch\/fr\/","name":"Gestione e qualit\u00e0 MQ","description":"Piattaforma per sistemi di gestione integrati.","publisher":{"@id":"https:\/\/www.m-q.ch\/fr\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.m-q.ch\/fr\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"it-IT"},{"@type":"Organization","@id":"https:\/\/www.m-q.ch\/fr\/#organization","name":"Galledia Fachmedien AG","url":"https:\/\/www.m-q.ch\/fr\/","logo":{"@type":"ImageObject","inLanguage":"it-IT","@id":"https:\/\/www.m-q.ch\/fr\/#\/schema\/logo\/image\/","url":"https:\/\/www.m-q.ch\/wp-content\/uploads\/2020\/12\/cropped-logo_small.png","contentUrl":"https:\/\/www.m-q.ch\/wp-content\/uploads\/2020\/12\/cropped-logo_small.png","width":512,"height":512,"caption":"Galledia Fachmedien AG"},"image":{"@id":"https:\/\/www.m-q.ch\/fr\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/ManagementUndQualitaet","https:\/\/www.linkedin.com\/showcase\/17982321\/admin\/"]},{"@type":"Person","@id":"https:\/\/www.m-q.ch\/fr\/#\/schema\/person\/47d540e081acd98ccbeb69b55df653d7","name":"Roger Str\u00e4ssle","image":{"@type":"ImageObject","inLanguage":"it-IT","@id":"https:\/\/www.m-q.ch\/fr\/#\/schema\/person\/image\/","url":"https:\/\/secure.gravatar.com\/avatar\/e4dde3046d8a184d2e2d27651a418883?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/e4dde3046d8a184d2e2d27651a418883?s=96&d=mm&r=g","caption":"Roger Str\u00e4ssle"},"url":"https:\/\/www.m-q.ch\/it\/author\/roger-straessle\/"}]}},"_links":{"self":[{"href":"https:\/\/www.m-q.ch\/it\/wp-json\/wp\/v2\/posts\/3912","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.m-q.ch\/it\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.m-q.ch\/it\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.m-q.ch\/it\/wp-json\/wp\/v2\/users\/35"}],"replies":[{"embeddable":true,"href":"https:\/\/www.m-q.ch\/it\/wp-json\/wp\/v2\/comments?post=3912"}],"version-history":[{"count":1,"href":"https:\/\/www.m-q.ch\/it\/wp-json\/wp\/v2\/posts\/3912\/revisions"}],"predecessor-version":[{"id":3914,"href":"https:\/\/www.m-q.ch\/it\/wp-json\/wp\/v2\/posts\/3912\/revisions\/3914"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.m-q.ch\/it\/wp-json\/wp\/v2\/media\/3913"}],"wp:attachment":[{"href":"https:\/\/www.m-q.ch\/it\/wp-json\/wp\/v2\/media?parent=3912"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.m-q.ch\/it\/wp-json\/wp\/v2\/categories?post=3912"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.m-q.ch\/it\/wp-json\/wp\/v2\/tags?post=3912"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}